XJPX
2931
Market cap295mUSD
Jul 10, Last price
345.00JPY
1D
0.29%
1Q
-14.18%
Jan 2017
-73.21%
IPO
108.84%
Name
Euglena Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Euglena Co., Ltd. is a Japanese enterprise specializing in the research, development, cultivation, and marketing of microalgae. Its operations are structured around two primary divisions: Healthcare Business and Energy/Environment Business. The company manufactures and sells a variety of euglena-derived food items and cosmetics. Additionally, it offers a broad portfolio of consumer goods, such as health foods, beverages, confectionery, and sports nutrition products. Furthermore, Euglena is engaged in pioneering biofuel and environmental technologies leveraging microalgae, and it makes strategic investments in the biotechnology sector. Its merchandise is distributed through numerous retail channels, including convenience stores, pharmacies, grocery stores, beauty parlors, and various specialty retailers. The company was established in Tokyo, Japan, in 2005.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2021‑09 | 2020‑12 | 2020‑09 | 2019‑12 | 2019‑09 | 2018‑12 | 2018‑09 | 2017‑12 | 2017‑09 | 2016‑12 | 2016‑09 | |
| Income | ||||||||||||||||
Revenues | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Unusual Expense (Income) | ||||||||||||||||
NOPBT | ||||||||||||||||
NOPBT Margin | ||||||||||||||||
Operating Taxes | ||||||||||||||||
Tax Rate | ||||||||||||||||
NOPAT | ||||||||||||||||
Net income | ||||||||||||||||
Dividends | ||||||||||||||||
Dividend yield | ||||||||||||||||
Proceeds from repurchase of equity | ||||||||||||||||
BB yield | ||||||||||||||||
| Debt | ||||||||||||||||
Debt current | ||||||||||||||||
Long-term debt | ||||||||||||||||
Deferred revenue | ||||||||||||||||
Other long-term liabilities | ||||||||||||||||
Net debt | ||||||||||||||||
| Cash flow | ||||||||||||||||
Cash from operating activities | ||||||||||||||||
CAPEX | ||||||||||||||||
Cash from investing activities | ||||||||||||||||
Cash from financing activities | ||||||||||||||||
FCF | ||||||||||||||||
| Balance | ||||||||||||||||
Cash | ||||||||||||||||
Long term investments | ||||||||||||||||
Excess cash | ||||||||||||||||
Stockholders' equity | ||||||||||||||||
Invested Capital | ||||||||||||||||
ROIC | ||||||||||||||||
ROCE | ||||||||||||||||
| EV | ||||||||||||||||
Common stock shares outstanding | ||||||||||||||||
Price | ||||||||||||||||
Market cap | ||||||||||||||||
EV | ||||||||||||||||
EBITDA | ||||||||||||||||
EV/EBITDA | ||||||||||||||||
Interest | ||||||||||||||||
Interest/NOPBT | ||||||||||||||||